Moneycontrol PRO
Loans
Loans
HomeNewsCipla

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Switch to Cipla from Ranbaxy Labs: Joshi

    Sharmila Joshi, Head of Equity, Peerless Securities is of the view that one can switch to Cipla from Ranbaxy Laboratories.

  • Book profits in Cipla: Jagannadham Thununguntla

    Jagannadham Thununguntla, Strategist & Head of Research at SMC Global Securities Limited is of the view that short term trader can book profits in Cipla but with a medium to long term view one can hold it.

  • Book partial profits in Cipla around Rs 450: Parag Doctor

    According to Parag Doctor, Head - Trading Strategies at Keynote Capital's Ltd, one can book partial profits in Cipla around Rs 450. It has been a laggard as compared to the other pharma stocks in the Nifty and it is pretty much now in an uptrend and trying to get to similar levels, which have been seen by the other stocks.

  • Sell Cipla, says Sudarshan Sukhani

    One can sell Cipla, says Sudarshan Sukhani of s2analytics.com.

  • Super Six: Top chart picks for April 29

    On CNBC-TV18's show Super Six, market gurus Vishal Kshatriya of Edelweiss, Rakesh Gandhi of FRR Shares and Shardul Kulkarni of Angel Broking, place their bets on two stocks each, thus offering investors a variety of options to choose from. Investors can read into the detailed analysis before agreeing to any or all the bets.

  • Super Six buy/sell call for April 23

    On CNBC-TV18's show Super Six, market gurus Rajesh Jain, Religare Securities, Vikrant Jadeja, vibranttrades.com and Vishal Malkan, malkansview.com, place their bets on two stocks each, thus offering investors a variety of options to choose from.

  • Buy Cipla, ICICI Bank: Agarwal

    Rajesh Agarwal, Head of Research, Eastern Financiers is of the view that Cipla, ICICI Bank and ITC seems to be a good buy for a longer term horizon.

  • Cipla has target of Rs 416: Jitendra Panda

    Jitendra Panda, Capital First Securities is of the view that Cipla has target of Rs 416.

  • 6 stocks likely to see lot of action today

    On CNBC-TV18's show Super Six, market gurus Shardul Kulkarni Angel Broking, Rajeev Agarwal, dynamixresearch.in and Vikrant Jadeja, Vibrant Trades share, place their bets on two stocks each, thus offering investors a variety of options to choose from.

  • Buy Cipla, says Sudarshan Sukhani

    One can buy Cipla , says Sudarshan Sukhani of s2analytics.com.

  • Super Six short term picks for April 9

    On CNBC-TV18's show Super Six, market gurus Shardul Kulkarni Angel Broking, Rajeev Agarwal, dynamixresearch.in and Vikrant Jadeja, Vibrant Trades share, place their bets on two stocks each, thus offering investors a variety of options to choose from.

  • Buy Cipla: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the opinion that one can buy Cipla.

  • Hold Cipla till Rs 410: Tulsian

    SP Tulsian, sptulsian.com is of the view that one should hold Cipla Rs 410.

  • Prefer Dr Reddy, Cipla over Shasun Pharma: Sukhani

    Sudarshan Sukhani, s2analytics.com advises to switch from Shasun Pharmaceuticals to Dr Reddy and Cipla.

  • Sukhani upbeat on Cipla, Dr Reddys Labs

    Sudarshan Sukhani, s2analytics.com is upbeat on Cipla and Dr Reddys Labs.

  • Buy Cipla; target Rs 396: Jitendra Panda

    Jitendra Panda of Capital First Securities feels that one can buy Cipla with a target of Rs 396.

  • Chirag Talati bullish on Cipla

    Chirag Talati, Pharma Analyst at Espirito Santo Securities is bullish on Cipla.

  • 6 stock ideas to liven up your trade

    On CNBC-TV18's show Super Six, market gurus Vishal Malkan, malkansview.com, Vishal Kshatriya, Edelweiss and Vikrant Jadeja, vibranttrades.com, place their bets on two stocks each, thus offering investors a variety of options to choose from.

  • Buy Cipla, Ranbaxy, HUL on dips: Sukhani

    Sudarshan Sukhani of s2analytics.com advises trader to buy Cipla, Ranbaxy and HUL on dips.

  • Go long in Cipla, says Sudarshan Sukhani

    One should go long in Cipla and it can test Rs 410-415, says Sudarshan Sukhani of s2analytics.com.

  • 6 stocks likely to see lot of action on March 19

    On CNBC-TV18's show Super Six, market gurus Rajesh Jain, Religare Sec, Manas Jaiswal, manasjaiswal.com and Shardul Kulkarni, Angel Broking, place their bets on two stocks each, thus offering investors a variety of options to choose from.

  • Buy Cipla, says Sudarshan Sukhani

    Buy Cipla, says Sudarshan Sukhani of s2analytics.com.

  • Buying opportunity seen in Cipla, HPCL, BPCL: Sukhani

    Buying opportunity is seen in Cipla, HPCL and BPCL, says Sudarshan Sukhani, s2analytics.com.

  • VK Sharma's trading tips for Karnataka Bank & Cipla

    In an interview to CNBC-TV18, VK Sharma of HDFC Securities shared his reading and outlook on Futures and Options market and specific stocks.

  • Buy Cipla 380 call at around Rs 8, says Sharma

    VK Sharma of HDFC Securities advised buying Cipla 380 call at around Rs 8 with a stop loss at Rs 5.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347